Research and Markets (http://www.researchandmarkets.com/reports/c91850) has announced the addition of “Concepts in Genetic Medicine” to their offering.
Concepts in Genetic Medicine offer a coherent collection of uniformly organized short reviews in the field of therapeutic genetic medicine. Each chapter focuses on a current topic (“concept”) to elucidate issues in development of genetic treatments for discuses, presenting critical challenges, strategies for addressing them, and future directions.
Key Topics: |
 |
– The Evolution of Human Gene Therapy. A Journey from Excessive Hype to Excessive Diffidence to Realty |
– Murine Leukemia Virus Based Vectors |
– Lentivirus Vectors |
– Adenoviral Vectors: History and Perspective |
– Adeno-associated Virus Vectors |
– The Glass is Half Full: the Goal of Long-term delivery may be Approachable Using SV40-derived Vectors |
– Herpes Simplex Virus Vectors |
– Nonviral Gene Delivery Systems |
– Therapeutic Gene Transfer to Skeletal Muscle |
– Gene Therapy for Cardiovascular Disease |
– Intra-articular Vector Delivery for Inflammatory Disease |
– The Respiratory System as a Platform for Gene Delivery |
– The Brain as a Target for Gene Therapy |
– Immune Responses to Viral vectors Injected Systemically or into the CNS |
– Cancer vaccines |
– Genetically Modified T cells for Human Gene Therapy |
– Lentiviral Vector Delivery of RNAi Triggers for the Treatment of HIV-1 Infection |
– The Manufacture of Genetic Viral Vector Products |
– The Manufacture of Adeno-associated Viral Vectors |
– Lentivirus Vector Manufacturing |
– Safety and Regulatory. |
– Assays for the Release of Viral Vector Gene Therapy Products for Clinical Trials |
– Safety of Retroviral Vectors: Regulatory and Technical Considerations |
– Assays for the Quality Control of Lentiviral Vectors |
– Assays for Non-viral vectors |
– Assays for the Release of Cellular Gene Therapy Products |
– Toxicology for Gene Therapy Products: Concepts and Challenges |
– Regulatory Aspects of Gene Therapy Medicinal Products in the European Union |
– Venture Capital and Biotechnology Startups |
– The role of Investment Banking in the Growth of Biotechnology Companies |
– Managing Reimbursment for Gene Therapy Products |
For more information visit http://www.researchandmarkets.com/reports/c91850.
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax: +353 1 4100 980